Mirage News
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led by researchers at Washington University School of Medicine in St. Louis. The clinical trial evaluated the safety and efficacy of an innovative CAR-T cell immunotherapy that
Read More
New Immunotherapy Offers Hope for Aggressive T Cell Cancers | Mirage News
Mirage News
16:22
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led by researchers at Washington University School of Medicine in St. Louis. The clinical trial evaluated the safety and efficacy of an innovative CAR-T cell immunotherapy that
